CN Patent

CN106632240A — 一种2‑甲基‑5‑(5‑溴吡啶‑2‑基)四氮唑的制备方法

Assigned to Shandong Xuan Pharmaceutical Technology Co Ltd · Expires 2017-05-10 · 9y expired

What this patent protects

本发明涉及式涉及一种2‑甲基‑5‑(5‑溴吡啶‑2‑基)四氮唑的新方法，该方法采用甲醛为原料，反应工艺简便、安全性高、收率高，并且可以量产。

USPTO Abstract

本发明涉及式涉及一种2‑甲基‑5‑(5‑溴吡啶‑2‑基)四氮唑的新方法，该方法采用甲醛为原料，反应工艺简便、安全性高、收率高，并且可以量产。

Drugs covered by this patent

tedizolid-phosphate (TEDIZOLID PHOSPHATE)

Patent Metadata

Patent number: CN106632240A
Jurisdiction: CN
Classification: —
Expires: 2017-05-10
Drug substance claim: No
Drug product claim: No
Assignee: Shandong Xuan Pharmaceutical Technology Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.